X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gy range 10-100 (312) 312
radiology and nuclear medicine (301) 301
index medicus (291) 291
radiotherapy (289) 289
hematology, oncology and palliative medicine (287) 287
radiology (287) 287
humans (278) 278
oncology (260) 260
radiology, nuclear medicine & medical imaging (259) 259
patients (247) 247
male (224) 224
middle aged (223) 223
female (221) 221
aged (212) 212
neoplasms (197) 197
radiation (189) 189
radiation doses (173) 173
cancer (162) 162
adult (161) 161
radiotherapy dosage (153) 153
care and treatment (121) 121
aged, 80 and over (118) 118
toxicity (117) 117
chemotherapy (100) 100
treatment outcome (99) 99
retrospective studies (96) 96
gy range 01-10 (77) 77
surgery (72) 72
irradiation (68) 68
disease-free survival (67) 67
time factors (66) 66
analysis (65) 65
multivariate analysis (65) 65
radiation hazards (63) 63
follow-up studies (58) 58
dose fractionation (55) 55
lungs (55) 55
nuclear radiation (54) 54
clinical trials (52) 52
medical colleges (52) 52
radiosurgery - methods (52) 52
radiation-therapy (51) 51
tumor burden (49) 49
prospective studies (48) 48
young adult (48) 48
radiotherapy, intensity-modulated - methods (47) 47
survival rate (44) 44
adolescent (42) 42
radiosurgery (41) 41
risk factors (41) 41
tumors (41) 41
dosimetry (39) 39
health aspects (39) 39
prostate (39) 39
radiosurgery - adverse effects (39) 39
computerized tomography (37) 37
carcinoma (34) 34
prostatic neoplasms - radiotherapy (33) 33
radiotherapy planning, computer-assisted - methods (33) 33
antineoplastic combined chemotherapy protocols - therapeutic use (32) 32
mammary glands (32) 32
survival (32) 32
analysis of variance (31) 31
head (31) 31
images (31) 31
organs at risk - radiation effects (31) 31
article (29) 29
metastases (29) 29
metastasis (29) 29
patient outcomes (29) 29
planning (29) 29
proton beams (29) 29
trial (29) 29
brachytherapy (28) 28
child (28) 28
dose-response relationship, radiation (28) 28
lung neoplasms - pathology (28) 28
oncology, experimental (28) 28
prognosis (28) 28
research (28) 28
biomedical radiography (27) 27
chemoradiotherapy - methods (27) 27
neoplasm staging (27) 27
chemoradiotherapy - adverse effects (26) 26
feasibility studies (26) 26
lymph nodes (26) 26
proton therapy - methods (26) 26
radiation injuries - prevention & control (26) 26
therapy (26) 26
carcinoma, non-small-cell lung - pathology (25) 25
neoplasm recurrence, local - mortality (25) 25
hazards (24) 24
radiotherapy, intensity-modulated - adverse effects (24) 24
randomized-trial (24) 24
sects (24) 24
brain (23) 23
carcinoma, squamous cell - pathology (23) 23
outcomes (23) 23
prostate cancer (23) 23
combined modality therapy - methods (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 98, Issue 2, pp. 275 - 285
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 2, pp. 368 - 375
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 5, pp. 1352 - 1358
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 5, pp. 989 - 996
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 4, pp. 757 - 764
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 97, Issue 5, pp. 976 - 985
Purpose SpaceOAR, a Food and Drug Administration–approved hydrogel intended to create a rectal–prostate space, was evaluated in a single-blind phase III trial... 
Radiology | Hematology, Oncology and Palliative Medicine | LOW-RISK | ONCOLOGY | INTENSITY-MODULATED RADIOTHERAPY | PROTON THERAPY | RANDOMIZED-TRIAL | INTERMEDIATE | PATIENT | QUALITY-OF-LIFE | OUTCOMES | DOSE-RATE BRACHYTHERAPY | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Radiotherapy, Image-Guided - psychology | United States - epidemiology | Prostatic Neoplasms - radiotherapy | Prevalence | Radiotherapy, Image-Guided - statistics & numerical data | Follow-Up Studies | Humans | Middle Aged | Male | Rectal Diseases - psychology | Rectal Diseases - prevention & control | Radiation Injuries - psychology | Adult | Dose Fractionation | Quality of Life - psychology | Radiation Protection - instrumentation | Risk Factors | Treatment Outcome | Radiotherapy, Conformal - psychology | Radiotherapy, Conformal - statistics & numerical data | Prostatic Neoplasms - psychology | Prostatic Neoplasms - epidemiology | Radiation Injuries - epidemiology | Radiation Injuries - prevention & control | Rectal Diseases - epidemiology | Aged | Radiation Protection - statistics & numerical data | Causality | Longitudinal Studies | Radiotherapy, Conformal - methods | Clinical trials | Hospitals | Radiotherapy | Radiation | Analysis | Index Medicus | PROSTATE | HYDROGELS | NEOPLASMS | RECTUM | MEN | RADIOLOGY AND NUCLEAR MEDICINE | TOXICITY | RADIOTHERAPY | GY RANGE 10-100
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 5, pp. 976 - 985
Purpose To perform a prospective, multi-institutional, phase 2 study of a substantial decrease in concurrent chemoradiation therapy (CRT) intensity as primary... 
Radiology | Hematology, Oncology and Palliative Medicine | WEEKLY CISPLATIN | LATE TOXICITY | ONCOLOGY | POSITIVE HEAD | RANDOMIZED-TRIAL | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NECK-CANCER | CONCURRENT CHEMORADIOTHERAPY | RADIATION-THERAPY | Lymph Node Excision | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Cyclin-Dependent Kinase Inhibitor p16 | Stomatitis - pathology | Adult | Female | Radiotherapy Dosage | Chemoradiotherapy - methods | Papillomavirus Infections - complications | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Oropharyngeal Neoplasms - virology | Stomatitis - etiology | Biopsy | Smoking - epidemiology | Neoplasm Proteins - analysis | Oropharyngeal Neoplasms - chemistry | Papillomaviridae | Aged | Patient Compliance | Papillomaviruses | Sects | Medical colleges | Care and treatment | Squamous cell carcinoma | Clinical trials | Papillomavirus infections | Index Medicus | LYMPH NODES | RADIATION HAZARDS | RADIOLOGY AND NUCLEAR MEDICINE | TOXICITY | RADIOTHERAPY | GY RANGE 10-100 | CHEMOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 4, pp. 755 - 765
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2017, Volume 98, Issue 2, pp. 286 - 295
Purpose To report the genitourinary (GU) and gastrointestinal (GI) morbidity and erectile dysfunction in a randomized trial comparing 2 methods of dose... 
Radiology | Hematology, Oncology and Palliative Medicine | CONFORMAL RADIATION-THERAPY | ONCOLOGY | CLINICALLY LOCALIZED ADENOCARCINOMA | INTENSITY-MODULATED RADIOTHERAPY | TOXICITY | EXPERIENCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - radiotherapy | Fecal Incontinence - epidemiology | Follow-Up Studies | Humans | Middle Aged | Urogenital System - radiation effects | Diarrhea - epidemiology | Male | Erectile Dysfunction - epidemiology | Pelvis | Gastrointestinal Hemorrhage - epidemiology | Feasibility Studies | Incidence | Time Factors | Aged, 80 and over | Gonadotropin-Releasing Hormone - therapeutic use | Fecal Incontinence - etiology | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Re-Irradiation - adverse effects | Brachytherapy - methods | Gonadotropin-Releasing Hormone - adverse effects | Logistic Models | Rectum - radiation effects | Combined Modality Therapy - adverse effects | Erectile Dysfunction - etiology | Urinary Incontinence - etiology | Re-Irradiation - methods | Disease-Free Survival | Gastrointestinal Hemorrhage - etiology | Urination Disorders - epidemiology | Urination Disorders - etiology | Intention to Treat Analysis | Androgen Antagonists - therapeutic use | Diarrhea - etiology | Radiotherapy, Conformal - adverse effects | Urinary Incontinence - epidemiology | Aged | Combined Modality Therapy - methods | Androgen Antagonists - adverse effects | Brachytherapy - adverse effects | Radioisotope brachytherapy | Impotence | Clinical trials | Health aspects | Prostate cancer | Risk factors | Morbidity | Prevalence studies (Epidemiology) | Index Medicus | PROSTATE | DISEASE INCIDENCE | EXTERNAL BEAM RADIATION THERAPY | NEOPLASMS | RADIATION HAZARDS | MEN | RADIOLOGY AND NUCLEAR MEDICINE | BRACHYTHERAPY | GY RANGE 10-100
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 97, Issue 1, pp. 146 - 154
Journal Article